Login
Home
Charts
Search
Watchlist
Products

Star Imaging and Path Lab Ltd

STARIMAGIN·BSE
76.49+2.33%Wed, 23 Sept '26

Star Imaging and Path Lab Ltd

STARIMAGIN
BSE
76.49
+2.33%
|Wed, 23 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
133Cr
Close
Close Price
76.49
Industry
Industry
Diagnostics
PE
Price To Earnings
6.92
PS
Price To Sales
1.51
Revenue
Revenue
89Cr
Rev Gr TTM
Revenue Growth TTM
6.02%
PAT Gr TTM
PAT Growth TTM
20.65%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2024Mar 2025Sep 2025Mar 2026
Revenue
RevenueCr
43414543
Growth YoY
Revenue Growth YoY%
6.15.9
Expenses
ExpensesCr
31242827
Operating Profit
Operating ProfitCr
12171716
OPM
OPM%
27.541.338.236.7
Other Income
Other IncomeCr
0001
Interest Expense
Interest ExpenseCr
1111
Depreciation
DepreciationCr
2333
PBT
PBTCr
11161616
Tax
TaxCr
2343
PAT
PATCr
610109
Growth YoY
PAT Growth YoY%
61.1-5.2
NPM
NPM%
14.623.822.221.3
EPS
EPS
0.00.05.85.3
QuarterSep 2024Mar 2025Sep 2025Mar 2026
Revenue
RevenueCr
43414543
Growth YoY
Revenue Growth YoY%
6.15.9
Expenses
ExpensesCr
31242827
Operating Profit
Operating ProfitCr
12171716
OPM
OPM%
27.541.338.236.7
Other Income
Other IncomeCr
0001
Interest Expense
Interest ExpenseCr
1111
Depreciation
DepreciationCr
2333
PBT
PBTCr
11161616
Tax
TaxCr
2343
PAT
PATCr
610109
Growth YoY
PAT Growth YoY%
61.1-5.2
NPM
NPM%
14.623.822.221.3
EPS
EPS
0.00.05.85.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
6959798489
Growth
Revenue Growth%
-15.334.66.06.0
Expenses
ExpensesCr
5453565555
Operating Profit
Operating ProfitCr
156222933
OPM
OPM%
21.29.928.534.337.5
Other Income
Other IncomeCr
00101
Interest Expense
Interest ExpenseCr
22232
Depreciation
DepreciationCr
43556
PBT
PBTCr
91162126
Tax
TaxCr
30457
PAT
PATCr
61121619
Growth
PAT Growth%
-90.72,036.528.120.7
NPM
NPM%
9.11.015.819.121.8
EPS
EPS
42.03.982.811.811.1
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
6959798489
Growth
Revenue Growth%
-15.334.66.06.0
Expenses
ExpensesCr
5453565555
Operating Profit
Operating ProfitCr
156222933
OPM
OPM%
21.29.928.534.337.5
Other Income
Other IncomeCr
00101
Interest Expense
Interest ExpenseCr
22232
Depreciation
DepreciationCr
43556
PBT
PBTCr
91162126
Tax
TaxCr
30457
PAT
PATCr
61121619
Growth
PAT Growth%
-90.72,036.528.120.7
NPM
NPM%
9.11.015.819.121.8
EPS
EPS
42.03.982.811.811.1

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
2221417
Reserves
ReservesCr
1717303499
Current Liabilities
Current LiabilitiesCr
2126333429
Non Current Liabilities
Non Current LiabilitiesCr
191618179
Total Liabilities
Total LiabilitiesCr
58618298154
Current Assets
Current AssetsCr
32265367115
Non Current Assets
Non Current AssetsCr
2735283139
Total Assets
Total AssetsCr
58618298154
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
2221417
Reserves
ReservesCr
1717303499
Current Liabilities
Current LiabilitiesCr
2126333429
Non Current Liabilities
Non Current LiabilitiesCr
191618179
Total Liabilities
Total LiabilitiesCr
58618298154
Current Assets
Current AssetsCr
32265367115
Non Current Assets
Non Current AssetsCr
2735283139
Total Assets
Total AssetsCr
58618298154

Cash Flow

Consolidated
Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
14518-323
Investing Cash Flow
Investing Cash FlowCr
-4-7-7-7-13
Financing Cash Flow
Financing Cash FlowCr
-7-52036
Net Cash Flow
Net Cash FlowCr
3-713-1046
Free Cash Flow
Free Cash FlowCr
10-211-713
CFO To PAT
CFO To PAT%
228.9904.4147.3-16.5121.2
CFO To EBITDA
CFO To EBITDA%
98.190.681.7-9.270.4
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
14518-323
Investing Cash Flow
Investing Cash FlowCr
-4-7-7-7-13
Financing Cash Flow
Financing Cash FlowCr
-7-52036
Net Cash Flow
Net Cash FlowCr
3-713-1046
Free Cash Flow
Free Cash FlowCr
10-211-713
CFO To PAT
CFO To PAT%
228.9904.4147.3-16.5121.2
CFO To EBITDA
CFO To EBITDA%
98.190.681.7-9.270.4

Ratios

Consolidated
Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
81133
Price To Earnings
Price To Earnings
4.26.9
Price To Sales
Price To Sales
0.91.5
Price To Book
Price To Book
0.71.1
EV To EBITDA
EV To EBITDA
1.53.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
52.548.254.162.964.064.0
OPM
OPM%
21.29.928.534.337.537.5
NPM
NPM%
9.11.015.819.121.821.8
ROCE
ROCE%
23.65.829.729.920.620.6
ROE
ROE%
34.33.139.733.816.616.6
ROA
ROA%
10.80.915.316.312.512.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
81133
Price To Earnings
Price To Earnings
4.26.9
Price To Sales
Price To Sales
0.91.5
Price To Book
Price To Book
0.71.1
EV To EBITDA
EV To EBITDA
1.53.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
52.548.254.162.964.064.0
OPM
OPM%
21.29.928.534.337.537.5
NPM
NPM%
9.11.015.819.121.821.8
ROCE
ROCE%
23.65.829.729.920.620.6
ROE
ROE%
34.33.139.733.816.616.6
ROA
ROA%
10.80.915.316.312.512.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Star Imaging and Path Lab Ltd

  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/eyhoi4wpqjug2jshhlunrvg1.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/n6agrostwa5b644y9hp9rsso.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/g2e5bzf44m6z850ufw1sd2dr.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/ikckn8zfymtjaor1rck8xr67.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/q2u4d81plhg9zcan4y7wys0s.pdf

Concall Transcript Summaries — Star Imaging and Path Lab Ltd

  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/BSE%3ASTARIMAGIN/transcript-notes/202603/eyhoi4wpqjug2jshhlunrvg1.pdf